Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
FishGastro Study: Fish Consumption and Gastro-Intestinal Health
This study has been completed.
Sponsors and Collaborators: Institute of Food Research
Wageningen University
University of Jena
University of East Anglia
European Commission
Food Standards Agency, United Kingdom
Information provided by: Institute of Food Research
ClinicalTrials.gov Identifier: NCT00145015
  Purpose

The purpose of the study is to determine whether increasing the dietary intake of n-3 fatty acids by the consumption of oil-rich fish reduces the risk of developing colorectal cancer.


Condition Intervention
Colorectal Cancer
Ulcerative Colitis
Polyps
Behavioral: Increased dietary intake of salmon or cod

Genetics Home Reference related topics: Crohn disease
MedlinePlus related topics: Cancer Colorectal Cancer Ulcerative Colitis
U.S. FDA Resources
Study Type: Interventional
Study Design: Diagnostic, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Fish Consumption and Gastro-Intestinal Health With Special Emphasis on Reduction of Risk of Colon Cancer and Inflammatory Bowel Disease

Further study details as provided by Institute of Food Research:

Primary Outcome Measures:
  • Apoptosis in colonic biopsy samples

Secondary Outcome Measures:
  • Cell proliferation
  • lymphocyte infiltration
  • circulating inflammatory markers (cytokines and prostaglandins)
  • tissue inflammatory markers (cytokines and prostaglandins)
  • faecal water cytotoxicity and genotoxicity
  • gene transcription

Estimated Enrollment: 270
Study Start Date: December 2004
Study Completion Date: April 2008
Detailed Description:

Epidemiological evidence from several countries supports a protective effect of fish consumption on cancer risk and gastrointestinal cancers in particular. Further evidence to support the idea that fish consumption is protective in relation to cancers of the GI tract is now emerging from the European Investigation into Cancer and Nutrition (EPIC).

The FISHGASTRO project is headed by the Institute of Food Research and includes groups from the University of East Anglia, the University of Wageningen, Netherlands and the University of Jena, Germany. The project focuses on assessing the impact of fish consumption on a range of markers of gastrointestinal health associated with ulcerative colitis or colon cancer and on looking at bio-accessibility of a range of nutrients from fish. We aim to recruit a total of 270 patients with gastrointestinal problems in the UK and Netherlands and take biopsy and blood samples before and after asking them to eat two extra portions of fish per week. One group will receive oil rich fish such as salmon while another will be asked to eat white fish. Changes in cell proliferation, apoptosis, inflammatory markers, gene expression and plasma levels of n-3 fatty acids will be compared to a control group only given standard nutritional advice.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Ulcerative Colitis Patient Group (Group 1):

  • Aged 18 - 80
  • Male or female
  • Diagnosed with ulcerative colitis
  • Attending gastroenterology clinic for routine colonoscopy check-up
  • Willing to increase dietary intake of fish for six months
  • Willing to undergo a flexible sigmoidoscopy examination

Polyps/Resection Group (Group 2):

  • Aged 18 - 80
  • Male or female
  • A history of polyps in the colon
  • Attending gastroenterology clinic for routine colonoscopy check-up
  • Willing to increase dietary intake of fish for six months
  • Willing to undergo a flexible sigmoidoscopy examination

Control Group (Group 3):

  • Aged 18 - 80
  • Male or female
  • Booked for a colonoscopy examination for the investigation of iron deficiency anaemia of unknown cause (no evidence of macroscopic disease found during examination)
  • Willing to increase dietary intake of fish for six months
  • Willing to undergo a flexible sigmoidoscopy examination

Exclusion Criteria:

Ulcerative Colitis Patient Group (Group 1) and Polyps/Resection Group (Group 2):

  • Allergic to fish
  • Receiving anticoagulant therapy
  • Diabetics
  • Pregnant or breast-feeding
  • Organ transplant recipients receiving immunosuppression therapy
  • Prosthetic heart valve
  • Allergic to pethidine
  • Previous diagnosis of bacterial endocarditis

Control Group (Group 3):

Same as Groups 1 and 2 plus:

  • Received a diagnosis of colorectal cancer following initial investigative colonoscopy (volunteer will be withdrawn from the study when diagnosed as requiring treatment)
  • Received a diagnosis of coeliac disease following initial investigative colonoscopy (volunteer will be withdrawn from the study when diagnosed as requiring a modified diet)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00145015

Locations
Netherlands
University of Wageningen
Wageningen, Netherlands
United Kingdom, Norfolk
Institute of Food Research
Norwich, Norfolk, United Kingdom, NR4 7UA
Sponsors and Collaborators
Institute of Food Research
Wageningen University
University of Jena
University of East Anglia
European Commission
Food Standards Agency, United Kingdom
Investigators
Principal Investigator: Elizabeth K Lund, PhD Institute of Food Research
  More Information

Click here for more information about the Fishgastro Study  This link exits the ClinicalTrials.gov site

Study ID Numbers: IFR02/2004
Study First Received: September 1, 2005
Last Updated: July 29, 2008
ClinicalTrials.gov Identifier: NCT00145015  
Health Authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency

Keywords provided by Institute of Food Research:
Intervention
Adults
Colorectal cancer
Nutrition
Fish
n-3 fatty acids
Apoptosis
Ulcerative colitis
Polyps
Gastro-intestinal tract

Study placed in the following topic categories:
Digestive System Neoplasms
Gastrointestinal Diseases
Ulcer
Colonic Diseases
Inflammatory Bowel Diseases
Colitis, Ulcerative
Polyps
Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms
Digestive System Diseases
Gastrointestinal Neoplasms
Gastroenteritis
Colitis
Colorectal Neoplasms

Additional relevant MeSH terms:
Neoplasms
Pathologic Processes
Neoplasms by Site

ClinicalTrials.gov processed this record on January 16, 2009